This content is machine translated Medical oncology A multidisciplinary approach to an innovative future The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates and healthcare professionals from around the world. Once again this year, the latest ground-breaking data was…
View Post 6 min This content is machine translated News from the world of oncology The hottest studies at a glance Every year, ESMO presents the most relevant research results of its congress within the framework of so-called Presidential Symposia. Also at this year’s virtual execution, the presentation of those studies…
View Post 6 min This content is machine translated ESMO 2018 in Munich Quantum leap in ovarian cancer? The SOLO-1 trial was one of the “hot” topics at this year’s ESMO. A PFS improvement of 70% with good tolerance and efficacy not only in recurrences suggest a relevant…
View Post 6 min This content is machine translated ESMO 2017 in Madrid Blocking the “escape route” for the tumor Upsets in first-line therapy of non-small cell EGFR-mutated lung cancer are imminent. With the FLAURA trial, osimertinib is confidently presenting itself for the first time as a treatment option for…
View Post 3 min This content is machine translated Tumor Treating Fields (TTF) What’s the story with the new process? At the 21st meeting of the Society For Neuro-Oncology, presentations included a phase III trial of Tumor Treating Fields (TTF) treatment in newly diagnosed glioblastoma. From ESMO ASIA come results…
View Post 5 min This content is machine translated ESMO in Copenhagen and Singapore Immunotherapy puts lung cancer experts in turmoil Pembrolizumab returned to the international stage of lung cancer therapy with a thunderclap during the presentation of the KEYNOTE 024 trial at the 2016 ESMO Congress in Copenhagen. Lectures on…
View Post 2 min This content is machine translated CDK4/6 inhibitors New class of drugs for breast cancer Adding the CDK4/6 inhibitor ribociclib to letrozole improved progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer, researchers reported at the ESMO 2016 Congress in Copenhagen.
View Post 8 min This content is machine translated ESMO Asia 2015 News on gastric cancer, NET, head and neck tumors and NSCLC At the first ESMO congress in Asia (Singapore), the results of various large studies were discussed and classified in terms of their international significance. The aim of the conference was…
View Post 6 min This content is machine translated ECCO/ESMO 2015 Care of cancer patients in European comparison At the European Cancer Congress in Vienna, there were new insights into the possible etiology of Hodgkin’s lymphoma. In addition, a comprehensive European comparison of cancer care was presented. In…
View Post 2 min This content is machine translated Personalized vaccination Each patient gets his own medicine Advances in so-called cancer vaccines were discussed at the ESMO Symposium on Immuno-oncology in Geneva. In the most elaborate study to date on this topic, researchers are currently investigating the…
View Post 3 min This content is machine translated Recurrent ovarian cancer Current developments give hope for a personalized approach At the ESMO Congress in Amsterdam, a review was given of the options available to date in the treatment of recurrent ovarian cancer. Therapy depends on the particular form of…
